ImaginAb Japan KK

In May 2014, ImaginAb launched ImaginAb Japan KK, a wholly-owned subsidiary headquartered in Tokyo, in order to better meet the commercial needs of several significant clinical development and partnership opportunities. Japan is a major market for imaging with Positron Emission Tomography (PET) and is important for advancement of ImaginAb’s global clinical activities. ImaginAb Japan KK will support the Company’s clinical efforts and collaborations in Japan, progress regulatory dialog, and explore partnership opportunities with Japanese biopharmaceutical companies.